Research analysts at Evercore ISI started coverage on shares of Exelon (NASDAQ:EXC - Get Free Report) in a report issued on Monday, Marketbeat Ratings reports. The firm set an "outperform" rating on the stock.
EXC has been the subject of several other reports. Morgan Stanley decreased their price target on shares of Exelon from $50.00 to $49.00 and set an "equal weight" rating for the company in a report on Thursday, September 25th. Weiss Ratings restated a "buy (b-)" rating on shares of Exelon in a report on Saturday, September 27th. UBS Group reiterated a "neutral" rating and issued a $48.00 target price (up from $47.00) on shares of Exelon in a research note on Friday, July 11th. Finally, KeyCorp reduced their target price on shares of Exelon from $39.00 to $37.00 and set an "underweight" rating for the company in a research note on Wednesday, July 16th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $48.11.
Read Our Latest Report on EXC
Exelon Stock Performance
Exelon stock opened at $46.79 on Monday. The firm's 50 day simple moving average is $44.28 and its 200-day simple moving average is $44.26. The company has a market cap of $47.26 billion, a P/E ratio of 17.79, a price-to-earnings-growth ratio of 2.68 and a beta of 0.40. The company has a debt-to-equity ratio of 1.66, a current ratio of 0.95 and a quick ratio of 0.85. Exelon has a fifty-two week low of $35.94 and a fifty-two week high of $48.11.
Exelon (NASDAQ:EXC - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.02. The business had revenue of $5.43 billion for the quarter, compared to the consensus estimate of $5.47 billion. Exelon had a net margin of 11.16% and a return on equity of 9.85%. The firm's quarterly revenue was up 1.2% compared to the same quarter last year. During the same period last year, the firm posted $0.47 earnings per share. Exelon has set its FY 2025 guidance at 2.640-2.740 EPS. As a group, equities research analysts predict that Exelon will post 2.64 EPS for the current year.
Institutional Trading of Exelon
Institutional investors and hedge funds have recently modified their holdings of the company. Norges Bank bought a new stake in Exelon in the 2nd quarter valued at $589,122,000. Nuveen LLC bought a new stake in Exelon in the 1st quarter valued at $285,428,000. ATLAS Infrastructure Partners UK Ltd. boosted its holdings in Exelon by 192.7% in the 1st quarter. ATLAS Infrastructure Partners UK Ltd. now owns 5,795,566 shares of the company's stock valued at $267,060,000 after purchasing an additional 3,815,722 shares during the period. Canada Pension Plan Investment Board boosted its holdings in Exelon by 164.3% in the 2nd quarter. Canada Pension Plan Investment Board now owns 5,593,627 shares of the company's stock valued at $242,875,000 after purchasing an additional 3,476,942 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in Exelon by 506.9% in the 1st quarter. AQR Capital Management LLC now owns 3,117,668 shares of the company's stock valued at $143,163,000 after purchasing an additional 2,603,959 shares during the period. 80.92% of the stock is currently owned by institutional investors and hedge funds.
Exelon Company Profile
(
Get Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.